Changes in peripheral blood B cell levels predict overall survival in patients with advanced liver cancer treated with immune target inhibitors
PD-1 inhibitors show efficacy in hepatocellular carcinoma (HCC), yet overall outcomes remain poor. In this retrospective study of 258 advanced HCC patients treated between 2019 ...